Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of mice and successfully edit a gene associated with Alzheimer's disease.
Using animal models, researchers demonstrate a potentially effective approach to treating blindness associated with genetic conditions by using mRNA and lipid nanoparticles.
Amyloid plaques can cling to newly developed bowl-shaped nanoparticles. The findings provide a new way to study the Alzheimer's related plaques and provides novel treatment options for dementia.
A new nanoparticle drug-delivery system resulted in unprecedented siRNA penetration across the intact blood-brain barrier. Researchers say the system could help doctors to treat secondary injuries associated with TBI that can result in Alzheimer's and other neurodegenerative disorders.
A new artificial intelligence technique could speed up complex physics simulations and help create multilayered nanoparticles, researchers say.
Researchers at MIT have developed a new drug delivering nanoparticle that is able to cross the blood-brain barrier. The nanoparticles carry two different drugs that can help shrink tumors and prevent them from growing back.
A new study outlines how researchers have been able to deliver concentrated amounts of drugs directly into the brains of rats by using ultrasound.
Researchers report they have discovered tiny magnetic nanoparticles from air pollution lodged in the human brain. They believe these nanoparticles could contribute to some cases of Alzheimer's.
Researchers are on pace to develop the next generation of functional materials that could enable the mapping of the complex neural connections in the brain.
Researchers develop a new technique to stimulate brain tissue by injecting magnetic nanoparticles and using external magnetic fields.
Researchers report they have been able to create tiny, biodegradable nanoparticles which are able to carry DNA to brain cancer cells in mice.
A Johns Hopkins team says its bioengineers have designed nanoparticles that can safely and predictably infiltrate deep into the brain when tested in rodent and human tissue.